The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute a simple solution

Intensive Care Med. 2022 Aug;48(8):1116-1117. doi: 10.1007/s00134-022-06744-8. Epub 2022 May 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants* / pharmacology
  • Anticoagulants* / therapeutic use
  • Factor Xa Inhibitors / therapeutic use
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Intensive Care Units
  • Venous Thromboembolism* / drug therapy
  • Venous Thromboembolism* / prevention & control

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Heparin, Low-Molecular-Weight